Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 43.63
-1.37 (-3.04%)
At close: Mar 9, 2026
Acrobiosystems Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | 172.77 | 123.83 | 153.59 | 203.73 | 174.21 | 115.88 | Upgrade
|
| Depreciation & Amortization | 50.95 | 50.95 | 42.02 | 34.5 | 13.94 | 5.64 | Upgrade
|
| Other Amortization | 21.33 | 21.33 | 17.45 | 9.6 | 3.99 | 1.71 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.35 | 0.35 | - | -0.21 | -0.28 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 39.76 | 39.76 | 37.76 | 24.22 | 5.7 | 3.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.48 | 1.48 | -5.37 | -21.63 | -8.1 | -0.61 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.17 | 2.17 | 1.71 | 1.03 | - | 0.96 | Upgrade
|
| Other Operating Activities | 33.55 | -5.81 | -9.34 | -4.43 | 0.4 | 0.56 | Upgrade
|
| Change in Accounts Receivable | -41.23 | -41.23 | -56.05 | -17.64 | -26.27 | -18.92 | Upgrade
|
| Change in Inventory | -83.21 | -83.21 | -81.32 | -52.91 | -34.44 | -13.26 | Upgrade
|
| Change in Accounts Payable | -6.14 | -6.14 | 29.81 | 37.22 | 17.4 | 6.97 | Upgrade
|
| Change in Other Net Operating Assets | -6.37 | -6.37 | -5.93 | 7.25 | 1.18 | 1.35 | Upgrade
|
| Operating Cash Flow | 173 | 84.71 | 111.2 | 202.19 | 138.01 | 96.5 | Upgrade
|
| Operating Cash Flow Growth | 29.40% | -23.82% | -45.00% | 46.51% | 43.02% | 372.94% | Upgrade
|
| Capital Expenditures | -157.12 | -167.26 | -128.69 | -284.29 | -61.7 | -14.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.98 | 4.71 | 0 | 0.35 | - | 0 | Upgrade
|
| Cash Acquisitions | -1.97 | -1.7 | 31.92 | - | - | - | Upgrade
|
| Investment in Securities | 275.06 | 276.98 | 0.19 | -913.61 | -722.05 | -25.01 | Upgrade
|
| Other Investing Activities | 74.01 | 0.12 | 5.26 | 21.11 | 8.05 | 0.6 | Upgrade
|
| Investing Cash Flow | 200.96 | 112.85 | -91.32 | -1,176 | -775.7 | -39.39 | Upgrade
|
| Short-Term Debt Issued | - | 97.46 | 6 | - | - | - | Upgrade
|
| Total Debt Issued | 65.06 | 97.46 | 6 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -16 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -26.78 | -31.93 | -17.61 | -9.54 | - | Upgrade
|
| Total Debt Repaid | -120.24 | -42.78 | -31.93 | -17.61 | -9.54 | - | Upgrade
|
| Net Debt Issued (Repaid) | -55.18 | 54.68 | -25.93 | -17.61 | -9.54 | - | Upgrade
|
| Issuance of Common Stock | 7.06 | 7.06 | - | 13.5 | 2,118 | 7.95 | Upgrade
|
| Repurchase of Common Stock | -12 | -12 | -10 | - | - | - | Upgrade
|
| Common Dividends Paid | -88.82 | -108.21 | -120 | -120 | - | -20 | Upgrade
|
| Other Financing Activities | 13.38 | - | - | - | -18.21 | -5.55 | Upgrade
|
| Financing Cash Flow | -135.56 | -58.48 | -155.93 | -124.11 | 2,090 | -17.6 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.51 | 7.65 | 13.85 | 6.42 | -2.26 | -3.11 | Upgrade
|
| Net Cash Flow | 243.92 | 146.73 | -122.2 | -1,092 | 1,450 | 36.39 | Upgrade
|
| Free Cash Flow | 15.89 | -82.56 | -17.49 | -82.1 | 76.31 | 81.52 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -6.39% | 690.64% | Upgrade
|
| Free Cash Flow Margin | 2.00% | -12.80% | -3.22% | -17.30% | 19.82% | 33.09% | Upgrade
|
| Free Cash Flow Per Share | 0.10 | -0.49 | -0.10 | -0.49 | 0.57 | 0.65 | Upgrade
|
| Cash Income Tax Paid | 20.66 | 60.55 | 48.67 | 36.43 | 41.4 | 23.02 | Upgrade
|
| Levered Free Cash Flow | -85.88 | -156.74 | -25.36 | -173.01 | 41.41 | 51.51 | Upgrade
|
| Unlevered Free Cash Flow | -82.48 | -154.52 | -23.67 | -171.17 | 42.13 | 51.51 | Upgrade
|
| Change in Working Capital | -149.35 | -149.35 | -126.63 | -44.62 | -51.85 | -30.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.